Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual orexin receptor antagonists in hypnotic-naive adults with insomnia
jRCT1031260489Completed
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of suvorexant and lemborexant in Insomnia (2 arms), sponsored by none. Primary endpoint: Clinical improvement rate after 52 weeks of DORA treatment. Started Apr 2018; status: completed.
02
Drugs
suvorexantlemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT1031260489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260489.